𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hereditary ovarian carcinoma. Biomarker studies

✍ Scribed by Henry T. Lynch; Guy S. Schuelke; Ibert C. Wells; Shih-Chuan Cheng; William J. Kimberling; Karen A. Biscone; Jane F. Lynch; B. Shannon Danes


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
571 KB
Volume
55
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Three ovarian-cancer-prone kindreds were studied, two of which contained identical twin sisters concordant for ovarian carcinoma. In one kindred, both identical twin sisters had daughters with ovarian carcinoma. In another kindred, one of the identical twin sisters had an ovarian-cancer-affected daughter. Ovarian carcinoma showed vertical transmission in all three families in a pattern consonant with an autosomal dominant mode of inheritance. Medical -genetic survey of each family included detailed questionnaires with retrieval of primary medical and pathology documents on cancer of all anatomic sites. Putative biomarker determinations included: (I) in vitro hyperdiploidy in dermal monolayer cultures; and (2) lower serum levels of alpha-L-fucosidase (5 275 IU/ml) in all cancer-affected patients and statistically significant lower levels in 50% risk individuals when compared to spouse and published controls (P = 0.04 and P = 0.0002, respectively). These findings are discussed in context with the eventual development of a risk factor profile which, given acceptable sensitivity and specificity, would enable identification of individuals who would be prime candidates for intensive surveillance/management programs.


πŸ“œ SIMILAR VOLUMES


Medication use and risk of ovarian carci
✍ James V. Lacey Jr.; Mark E. Sherman; Patricia Hartge; Arthur Schatzkin; Catherin πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 81 KB πŸ‘ 1 views

## Abstract Inflammation and gonadotropins are hypothesized to influence ovarian carcinogenesis. In a prospective study, we evaluated ovarian cancer risk associated with self‐reported use of medications that influence inflammation or gonadotropin levels. The Breast Cancer Detection Demonstration Pr

Early de novo ovarian carcinoma. A study
✍ Debra A. Bell; Robert E. Scully πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 661 KB

Background. The search for methods of early detection of ovarian carcinoma in recent years has emphasized the lack of information regarding the histologic features of early carcinoma or its precursor lesions; few examples of early de novo ovarian carcinoma have been reported. Methods. The clinicopa

Distribution of HER-2 overexpression in
✍ Estrid V. S. HΓΈgdall; Lise Christensen; Susanne K. Kjaer; Jan Blaakaer; Johannes πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 389 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The HER‐2 (Human Epidermal Growth factor receptor‐2, also known as c‐__erb__‐2/__neu__) protooncogene encodes a transmembrane receptor protein, __M__~r~ 185,000. Studies have shown that the HER‐2 oncogene is overexpressed in approximately 25–30% of ovarian carcinoma (OC)